Research Paper Volume 13, Issue 8 pp 11043—11060

High expression of CD52 in adipocytes: a potential therapeutic target for obesity with type 2 diabetes

Characterization of CD52 in preadipocytes and the process of adipocyte differentiation. (A) The expression levels of CD52 in preadipocyte by microarray analysis. (B) The expression levels of CD52 during preadipocytes differentiation by microarray analysis. (C, D) The expression levels of CD52 in preadipocyte between three obese people and three lean people by Real-time RT-PCR and western blot analysis. (E, F) The expression levels of CD52 during preadipocytes differentiation by Real-time RT-PCR and western blot analysis.

Figure 2. Characterization of CD52 in preadipocytes and the process of adipocyte differentiation. (A) The expression levels of CD52 in preadipocyte by microarray analysis. (B) The expression levels of CD52 during preadipocytes differentiation by microarray analysis. (C, D) The expression levels of CD52 in preadipocyte between three obese people and three lean people by Real-time RT-PCR and western blot analysis. (E, F) The expression levels of CD52 during preadipocytes differentiation by Real-time RT-PCR and western blot analysis.